Figure 1. Impaired hypoxic status regulation owing to mutations in Group 1 genes.

Mutations in VHL, SDH, HIF2A, PHD2, and FH genes may lead to activation of the transcription factor HIF-1 and its target genes that promote pseudohypoxic oncogenesis. See text for details.